All cancer types
Results
Phase 1
This trial looked at a drug called MOv18 IgE for people with advanced cancer. It was for people who’d had all the standard treatments available to them.
The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2021. The team analysed the results in 2022.
Recruitment start: 16 February 2016
Recruitment end: 30 July 2021
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr James Spicer
Cancer Research UK (Centre for Drug Development) - trial sponsor, regulatory@cancer.org.uk
NIHR Clinical Research Network: Cancer
The research team would like to thank all the patients who took part in this trial. By doing this, you’ve helped the research team learn more about cancer and how to treat it.
This is Cancer Research UK trial number CRUKD/14/001.
There is more information about this trial on the clinicaltrials.gov website (NCT02546921):
Last reviewed: 27 Jul 2022
CRUK internal database number: 5033
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
